Latest Breaking News On - Shinichiro nishishita - Page 15 : comparemela.com

Cancer Research UK and Sosei Heptares sign agreement to

HTL0039732 is a novel EP4 antagonist with potential to treat a wide range of cancers in combination with other immunotherapies.

United kingdomCity ofEleanor perkinFrazer hallNeurocrine biosciencesSosei heptaresHironoshin nomuraCandelle chongMatt barnesGenentech rocheEllie bennettNigel blackburnShinichiro nishishitaSosei heptareSosei group corporationMedicinal chemistry gordon research conference

Sosei Heptares Webinar Presentation for Q2 FY2022 Financial Results

Sosei Heptares Webinar Presentation for Q2 FY2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomEleanor perkinFrazer hallChris cargillSosei heptaresHironoshin nomuraMatt barnesDisclosurescandelle chongRelationshironoshin nomuraShinichiro nishishitaCompany home pageMedistrava consulting for international media mark swallowSosei group corporationSosei group corporation the companyGroup corporationHeptares therapeutics

Sosei Heptares Expands UK R&D Operations to Second Site

TOKYO, Japan and CAMBRIDGE, United Kingdom, May 26, 2022 (GLOBE NEWSWIRE) Sosei Group Corporation (“the Company”; TSE: 4565), world leader in G.

United kingdomEleanor perkinFrazer hallChris cargillNeurocrine biosciencesSosei heptaresHironoshin nomuraCandelle chongGenentech rocheShinichiro nishishitaSosei heptareSosei group corporationSosei groupCancer research united kingdomSosei group corporation the companyTokyo stock exchange

Sosei Heptares Expands UK R&D Operations to Second Site within Granta Park, Cambridge

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United kingdomEleanor perkinFrazer hallChris cargillNeurocrine biosciencesSosei heptaresHironoshin nomuraCandelle chongGenentech rocheShinichiro nishishitaSosei heptareSosei group corporationSosei groupCancer research united kingdomSosei group corporation the companyTokyo stock exchange

Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesAlexandria centerUnited kingdomEleanor perkinFrazer hallNancy thornberryNeurocrine biosciencesTom maniatisSosei heptaresHironoshin nomuraCharles zukerCandelle chongMatt barnesAnita kawatraGenentech roche